Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Profit After Tax (2016 - 2025)

Abeona Therapeutics (ABEO) has 15 years of Profit After Tax data on record, last reported at -$5.2 million in Q3 2025.

  • For Q3 2025, Profit After Tax rose 82.95% year-over-year to -$5.2 million; the TTM value through Sep 2025 reached $82.4 million, up 215.93%, while the annual FY2024 figure was -$63.7 million, 17.62% down from the prior year.
  • Profit After Tax reached -$5.2 million in Q3 2025 per ABEO's latest filing, down from $108.8 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $108.8 million in Q2 2025 and bottomed at -$46.7 million in Q4 2021.
  • Average Profit After Tax over 5 years is -$7.9 million, with a median of -$11.8 million recorded in 2023.
  • Peak YoY movement for Profit After Tax: crashed 306.49% in 2023, then soared 1369.52% in 2025.
  • A 5-year view of Profit After Tax shows it stood at -$46.7 million in 2021, then skyrocketed by 84.75% to -$7.1 million in 2022, then tumbled by 132.99% to -$16.6 million in 2023, then soared by 43.99% to -$9.3 million in 2024, then skyrocketed by 44.46% to -$5.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Profit After Tax were -$5.2 million in Q3 2025, $108.8 million in Q2 2025, and -$12.0 million in Q1 2025.